Swiss government launches Covid-19 scientific taskforce
A picture made available by the US National Institutes of Health (NIH) shows a transmission electron micrograph of SARS-CoV-2 virus particles, also known as 2019-nCoV, the virus that causes Covid-19, isolated from a patient.
Keystone / Niaid/national Institutes Of Hea
The federal authorities have set up a scientific taskforce to advise the Federal Council and to coordinate national research by universities into coronavirus.
This content was published on
2 minutes
Keystone-SDA/sb
Português
pt
Governo suíço lança força-tarefa contra a Covid-19
The “Covid-19 taskforce” will be led by Matthias Egger, president of the national research council of the Swiss National Science Foundation (SNSF), the government announcedExternal link on Tuesday.
The group will advise the government, interior ministry and other relevant federal and cantonal authorities. It will also identify areas of research and special measures or products that the Swiss scientific community could rapidly contribute to global efforts to fight the virus.
“The Swiss scientific community offers huge potential to have a positive influence on the outcome of the crisis via research, training or knowledge transfer,” the interior ministry said.
It will aim to coordinate coronavirus research being done into diagnostic tests, healthcare, clinical research and contact-tracing via new digital applications, as well as related ethical and legal issues.
More
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
The taskforce will build on a call by the SNSF on February 25 for proposals on research into coronaviruses “to tackle the current crisis and prepare for future likely epidemics”. A sum of CHF5 million ($5.2 million) has been earmarked for projects.
The SNSF has received 270 applications, according to Swiss public radio, RTS, on Tuesday. The majority of projects were biomedical, including studies of viruses and infections, the immune response in humans and the spread of the disease.
The selected projects “will provide a basis for the subsequent industrial development of active agents”. The grants available are CHF50,000-CHF300,000 per project.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss-backed ‘Hera’ asteroid mission hits key milestone with Mars flyby
This content was published on
According to the European Space Agency (ESA), the Red Planet’s gravity will tweak the probe’s path, cutting months off the journey and saving a lot of fuel.
Swiss man arrested over Geneva parcel bomb attacks
This content was published on
A 61-year-old Swiss man was arrested in Geneva in connection with the parcel bomb incidents that left a man and a 12-year-old girl seriously injured.
UN officials in Geneva report over 100 civilian executions in western Syria
This content was published on
Verification is ongoing, and the actual number is likely higher, said a UN spokesperson in Geneva. A Syrian NGO claims executions could exceed 1,000.
Swiss pharma giant Roche partners with Zealand Pharma on new obesity treatment
This content was published on
Roche announced that it has struck an exclusive deal with Denmark's Zealand Pharma to develop and market petrelintide, a new treatment for obesity.
Experts lower Swiss growth forecasts due to US trade tensions
This content was published on
The uncertainty caused by ongoing trade conflicts is making companies hesitant to make decisions, which significantly hinders investment.
Swiss abbot resumes role following abuse investigation
This content was published on
Scarcella was accused in the Catholic Church abuse scandal last autumn. In October 2024, the Vatican declared there was no evidence of abuse or harassment against him.
Swiss stock exchange operator SIX to cut 150 jobs in efficiency drive
This content was published on
"We're not revealing the number of job losses at each location at the moment," said a SIX spokesperson. However, there will be cuts in Switzerland as well.
Martin Pfister named new Swiss government minister
This content was published on
Pfister’s election keeps the linguistic balance of Switzerland’s government, but shifts gender balance to only two women.
Swiss interior minister meets UN leaders in New York for women’s rights session
This content was published on
The Swiss interior minister also held bilateral meetings with UN Secretary-General António Guterres and Sima Sami Bahous, Executive Director of UN Women
The image of foreigners in Switzerland has deteriorated
This content was published on
The Federal Statistical Office has found that Swiss people’s views of foreigners have worsened over the last couple of years.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
What Swiss researchers are doing to beat Covid-19
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
‘Anti-malaria drug can kill coronavirus’: Novartis chief
This content was published on
Swiss pharmaceutical giant Novartis believes the anti-malaria drug hydroxychloroquine offers one of the best hopes to combat coronavirus.
Covid-19 immunity testing to begin in some Swiss hospitals
This content was published on
The hospitals are planning to roll out testing to evaluate how many people have already been infected, including those who may have already be immune.
Global cooperation needed to prevent Covid-19 drugs ‘free-for-all’
This content was published on
Weaker countries may be pushed aside in the scramble for effective drugs to fight coronavirus, an infectious diseases expert fears.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.